Zimmer Biomet Holdings ZBH
NYSE ZBH
$99.01 -1.73 (-1.72%)
As of: Aug 20, 2026 · 3:59 PM EDT

Zimmer Biomet Holdings (ZBH) Cash & Equivalents Growth (3y) (2012 - 2026)

Zimmer Biomet Holdings (ZBH) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -13.31%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 34.27%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 8.10%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 8.16%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 40.74%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -2.57%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 2.72%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 38.28%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 32.23%
10 Zimmer Biomet Holdings 19.04 Bn 18.63 Bn 1.54 Bn 8.63%

Historic Data

Download Data
DateValue
Jun 30, 2026 8.63%
Mar 31, 2026 8.71%
Dec 31, 2025 16.36%
Sep 30, 2025 33.33%
Jun 30, 2025 12.96%
Mar 31, 2025 47.01%
Dec 31, 2024 11.60%
Sep 30, 2024 -14.79%
Jun 30, 2024 -26.13%
Mar 31, 2024 -18.44%
Dec 31, 2023 -19.67%
Sep 30, 2023 -32.91%
Jun 30, 2023 -23.47%
Mar 31, 2023 -48.61%
Dec 31, 2022 -15.28%
Sep 30, 2022 2.10%
Jun 30, 2022 -1.40%
Mar 31, 2022 -9.44%
Dec 31, 2021 -11.35%
Sep 30, 2021 20.57%